Several EU countries this week halted the use of the drug, which has been championed by U.S. President Donald Trump as an effective treatment for COVID-19. (bit.ly/3cgboAO)
France, Italy and Belgium followed a World Health Organization decision on Monday to pause a large trial of the drug on COVID-19 patients.
“It is important that properly designed, randomised clinical trials can be completed, with adjustments as needed, to generate the necessary evidence on benefits and risks of these medicines in COVID-19,” the European Medicines Agency said. (bit.ly/3cgboAO)
Randomized trials involve comparing drugs with a placebo, with neither doctors nor patients aware of who gets what.
The decades-old drug is approved for treating rheumatoid arthritis and lupus.
https://www.reuters.com/article/us-health-coronavirus-ema-hydroxychloroq/eu-regulator-wants-more-data-on-malaria-drugs-use-for-covid-19-idUSKBN235215
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.